Acta Pharmaceutica Sinica B : Impact Factor & More
eISSN: 2211-3843pISSN: 2211-3835
Open AccessShare this on:
Key Metrics
CiteScore 
15.9
Eigenfactor
< 0.001
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Pharmacology, Toxicology and Pharmaceutics (all)
SNIP
2.59
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B Journal Specifications
| Overview | |
| Publisher | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| Language | English |
| Frequency | Bi-monthly |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Insititute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Acta Pharmaceutica Sinica B ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Pharmaceutica Sinica B
Opening endothelial gap while decompressing matrix: A coordinated mechanism enhancing drug delivery in pancreatic cancer treatment.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Microthrombi targeted nano-micelle synchronizing endothelial gap opening and matrix decompression for augmenting drug perfusion within pancreatic cancer.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases
- 1 Jun 2026
- Acta Pharmaceutica Sinica B
Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
The mechanisms and strategies for Alzheimer's disease prevention: An update.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Two receptors, one molecule: Reprogramming bile acid signaling for cardioprotection.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Opening endothelial gap while decompressing matrix: A coordinated mechanism enhancing drug delivery in pancreatic cancer treatment.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Microthrombi targeted nano-micelle synchronizing endothelial gap opening and matrix decompression for augmenting drug perfusion within pancreatic cancer.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases
- 1 Jun 2026
- Acta Pharmaceutica Sinica B
Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
The mechanisms and strategies for Alzheimer's disease prevention: An update.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
Two receptors, one molecule: Reprogramming bile acid signaling for cardioprotection.
- 1 Jun 2026
- Acta pharmaceutica Sinica. B
FAQs on Acta Pharmaceutica Sinica B
How long has Acta Pharmaceutica Sinica B been actively publishing? 
What is the publishing frequency of Acta Pharmaceutica Sinica B?
How many articles did Acta Pharmaceutica Sinica B publish last year?
What is the eISSN & pISSN for Acta Pharmaceutica Sinica B?
What is Citescore for Acta Pharmaceutica Sinica B?
What is SNIP score for Acta Pharmaceutica Sinica B?
What is the SJR for Acta Pharmaceutica Sinica B?
Who is the publisher of Acta Pharmaceutica Sinica B?
